Editor’s Note: This article is a reprint. It was originally published June 30, 2019. Cancer kills an estimated 1,600 Americans each day. In China, 8,100 people a day succumb to the disease. It’s so common, it’s a rare individual who does not know someone who has been diagnosed with cancer — which is why the… Read More »
In this interview, Dr. Nathan Goodyear discusses the benefits of vitamin C in cancer treatment. We are both scheduled speakers at the Vitamin C International Consortium Institute’s annual conference in Tampa, Florida, September 9 and 10, 2022. Goodyear started out as a gynecologist and pelvic floor surgeon. Once out of residency, however, he noticed that… Read More »
Early results from a small study suggest that six-monthly injections of lenacapavir, an experimental HIV capsid inhibitor, can be used as part of a combination regimen for people starting HIV treatment, the 11th International AIDS Society Conference on HIV Science (IAS 2021) heard today. On Saturday, aidsmap reported on CAPELLA, a study of lenacapavir in treatment-experienced people failing… Read More »
FDA Approves Rezurock (belumosudil) for the Treatment of Patients with Chronic Graft-Versus-Host Disease (cGVHD) NEW YORK, NY / ACCESSWIRE / July 16, 2021 / Kadmon Holdings, Inc. (Nasdaq:KDMN) today announced that the U.S. Food and Drug Administration (FDA) has approved Rezurock™ (belumosudil) 200 mg once daily (QD) for the treatment of adult and pediatric patients… Read More »